Tested Applications
| Positive WB detected in | mouse liver tissue, human liver tissue, HEK-293 cells |
| Positive IHC detected in | human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
13737-1-AP targets CYP3A5 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag4674 Product name: Recombinant human CYP3A5 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 152-502 aa of BC033862 Sequence: YGDVLVRNLRREAEKGKPVTLKDIFGAYSMDVITGTSFGVNIDSLNNPQDPFVESTKKFLKFGFLDPLFLSIILFPFLTPVFEALNVSLFPKDTINFLSKSVNRMKKSRLNDKQKHRLDFLQLMIDSQNSKETESHKALSDLELAAQSIIFIFAGYETTSSVLSFTLYELATHPDVQQKLQKEIDAVLPNKAPPTYDAVVQMEYLDMVVNETLRLFPVAIRLERTCKKDVEINGVFIPKGSMVVIPTYALHHDPKYWTEPEEFRPERFSKKKDSIDPYIYTPFGTGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLDTQGLLQPEKPIVLKVDSRDGTLSGE Predict reactive species |
| Full Name | cytochrome P450, family 3, subfamily A, polypeptide 5 |
| Calculated Molecular Weight | 502 aa, 57 kDa |
| Observed Molecular Weight | 52 kDa |
| GenBank Accession Number | BC033862 |
| Gene Symbol | CYP3A5 |
| Gene ID (NCBI) | 1577 |
| RRID | AB_2090516 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P20815 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for CYP3A5 antibody 13737-1-AP | Download protocol |
| WB protocol for CYP3A5 antibody 13737-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The CYP3A5 polyclonal antibody (Cat# 13737-1-AP) has 3 total citations published in Int J Mol Sci, Front Oncol, and Oncotarget. The associated research fields include hepatocellular carcinoma prognostic signatures based on metabolic pathway phenotypes, gene expression reprogramming in liver cancer cells, and the role of alpha-ketoglutarate in suppressing NF-κB-mediated inflammation while enhancing PXR-regulated detoxification pathways.
| Species | Application | Title |
|---|---|---|
Int J Mol Sci Gene Expression Reprogramming by Citrate Supplementation Reduces HepG2 Cell Migration and Invasion | ||
Front Oncol Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes. | ||
Oncotarget Alpha-ketoglutarate suppresses the NF-κB-mediated inflammatory pathway and enhances the PXR-regulated detoxification pathway. |











